Dr. Christine Brennan is a Principal in Cambridge, MA, USA. Prior to joining NVF, she was Chief Business Officer at Vitae Pharmaceuticals. Previously, she was Executive Director and Head of Strategy & Operations in Strategic Alliances with Novartis Institutes of Biomedical Research. Prior to this, she held positions in biotechnology and mid-size pharma companies in business development and marketing at EnVivo Pharmaceuticals, Biovail Corp. and Cogent Neurosciences and was a Director at the venture capital company Fidelity Biosciences Group. She received her PhD in neuroscience from Dartmouth Medical School and completed a postdoctoral fellowship in developmental neurobiology at the National Institutes of Health.
SYDNEY | MELBOURNE | SINGAPORE | BANGKOK
If your deadline is just around the corner and you have tons of coursework piling up, contact us and we will ease your academic burden. We are ready to develop unique papers according to your requirements, no matter how strict they are. Our experts create writing masterpieces that earn our customers not only high grades but also a solid reputation from demanding professors. Don't waste your time and order our essay writing service today!
Novartis Venture Fund investing in innovative life science companies for patient benefit, creating attractive returns for entrepreneurs and investors.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
Money managers practicing “socially responsible investing” now control nearly $ trillion, representing 18% of all . assets under management. That figure has grown 76% in just two years… READ MORE